Hospital

High cost-sharing is a large barrier to insulin access, as are aspects of the Inflation Reduction Act of 2022.

Overall survival data were immature at the time of interim analysis and follow-up will continue to the next analysis.

The oral SGLT2 inhibitor has been shown to reduce blood sugar and improve glycemic control as an adjunct to diet and exercise.

Pipeline includes more than 100 products encompassing bone health, cancer care, immunosuppressants, ophthalmology.

The new strategy would propose annual COVID-19 vaccines, much like annual flu shots.

During the COVID-19 pandemic, patients were able to utilize telehealth services to receive care more conveniently, which may reduce the cost of care.

Patients who received the interventions reported improved anxiety and pain levels.

A recent study shows that heart patients who learn to cope with stress in group therapy are nearly 2 times less anxious and depressed.

NRTIs TAF and TDF are increasingly being used as preexposure prophylaxis (PrEP) to prevent HIV around the world.

The popularity of intermittent fasting, or time-restricted eating patterns, may not help control weight as well as other dieting methods.

OR-449 is being developed for both adult and pediatric patients with adrenocortical carcinoma, as well as other cancers known to express a high level of steroidogenic factor-1.

The impact of RSV includes serious financial challenges, strained relationships, and mental health concerns.

CAR T cell gel eliminated the residual tumor cells in almost all mouse models, allowing the mice to survive when they otherwise would have succumbed to tumor recurrence.

Analysis includes 11 individuals who sat in ergonomic chairs for 8 hours and only got up at the recommended times.

Matt Gibbs, president of Capital Rx, to discusses alternative career paths for students, including independently owned PBMs.

The device features advancements to improve patient care, eliminating or reducing the risk of blood leakage around valve implants.

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Sarah McDonald, cancer survivor and author of The Cancer Channel, discusses her experience battling 2 different unrelated cancers and the value oncology pharmacists could have provided with a greater presence on her care team.

Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.

Carina Dolan, PharmD, BCOP, senior director for Clinical Oncology and Pharmaceutical Outcomes at Vizient Inc, discusses the highlights and big picture moving forward for hospitals and health-system pharmacies.

18F-FDG PET/CT detects approximately 73% of tumor lesions, while 68Ga-FAPI finds approximately 94%.

Bruton’s tyrosine kinase inhibitor zanubrutinib (Brukinsa; BeiGene USA, Inc) approved for the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.

This is the first indication for tucatinib that extends beyond the treatment of advanced unresectable or metastatic HER2-positive breast cancer.

Older patients received cancer treatment less frequently during the pandemic, as did patients covered by Medicaid.

Key trends such as consolidation create an opportunity for independent pharmacies with a community-based approach.

Data from a randomized clinical trial supports previous clinical findings on SGLT2 inhibitors and their ability to slow the progression of chronic kidney disease.

This week's episode features Amina Abubakar, PharmD, AAHIVP, CEO of Avant Pharmacy & Wellness Center and president of Avant Institute, who discusses her experience in the pharmacy industry and the communities she serves.

The stool-test is the first-of-its-kind to detect CRC in adults aged 45 to 49 years, with a premarket approval submission planned to be sent to the FDA early in 2023.

Soft tissue reconstruction solutions can leverage a patient’s natural healing response.

Research shows that some unsuccessful switches from reference products to biosimilars may be attributed to patient perceptions of reduced efficacy and safety.